Inflammatory cell phenotypes in AAAs: Their role and potential as targets for therapy

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 8, 2015, Pages 1746-1755

  Dale, Matthew A ^a   Ruhlman, Melissa K ^a   Baxter, B Timothy ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

aneurysm; aorta; inflammation; lymphocytes; macrophages

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ADAPTIVE IMMUNITY; AORTA WALL; ARTICLE; ASYMPTOMATIC DISEASE; ATHEROSCLEROSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE COURSE; DISEASE EXACERBATION; DRUG TARGETING; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE ACTIVATION; MAST CELL; MORTALITY; NEUTROPHIL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; ABDOMINAL AORTA; ANIMAL; ANTAGONISTS AND INHIBITORS; AORTIC ANEURYSM, ABDOMINAL; DRUG EFFECTS; IMMUNOLOGY; MACROPHAGE; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION;

ANTIINFLAMMATORY AGENT; AUTACOID;

ADAPTIVE IMMUNITY; ANIMALS; ANTI-INFLAMMATORY AGENTS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; MACROPHAGES; MAST CELLS; MOLECULAR TARGETED THERAPY; NEUTROPHILS; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84938057019     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.305269     Document Type: Article

References (115)

1. Thom T, Haase N, Rosamond W, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006 113 e85 151. doi: 10.1161/CIRCULATIONAHA.105.171600
2. LeFevre ML, U.S. Preventive Services Task Force. Screening for abdominal aortic aneurysm: U.S. Preventive services task force recommendation statement. Ann Intern Med 2014 161 281 290. doi: 10.7326/M14-1204
3. Pande RL, Beckman JA., Abdominal aortic aneurysm: populations at risk and how to screen. J Vasc Interv Radiol 2008 19 6 Suppl S2 S8. doi: 10.1016/j.jvir.2008.03.010
4. Lederle FA, Johnson GR, Wilson SE, Gordon IL, Chute EP, Littooy FN, Krupski WC, Bandyk D, Barone GW, Graham LM, Hye RJ, Reinke DB., Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators. J Vasc Surg 1997 26 595 601
5. Powell JT, Greenhalgh RM., Clinical practice. Small abdominal aortic aneurysms. N Engl J Med 2003 348 1895 1901. doi: 10.1056/NEJMcp012641
6. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Acher CW, Ballard DJ., Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med 1997 126 441 449
7. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, Barone GW, Bandyk D, Moneta GL, Makhoul RG., The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000 160 1425 1430
8. Salem MK, Rayt HS, Hussey G, Rafelt S, Nelson CP, Sayers RD, Naylor AR, Nasim A., Should Asian men be included in abdominal aortic aneurysm screening programmes? Eur J Vasc Endovasc Surg 2009 38 748 749. doi: 10.1016/j.ejvs.2009.07.012
9. Blanchard JF, Armenian HK, Friesen PP., Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 2000 151 575 583
10. Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D, Goeddel LA, Hawkins CJ, Thompson RW., Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 2005 241 92 101
11. Nagashima H, Aoka Y, Sakomura Y, Sakuta A, Aomi S, Ishizuka N, Hagiwara N, Kawana M, Kasanuki H., A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 2002 36 158 163
12. Boucek RJ, Gunja-Smith Z, Noble NL, Simpson CF., Modulation by propranolol of the lysyl cross-links in aortic elastin and collagen of the aneurysm-prone Turkey. Biochem Pharmacol 1983 32 275 280
13. Brophy CM, Tilson JE, Tilson MD., Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm-prone blotchy mouse. J Surg Res 1989 46 330 332
14. Yamamoto D, Takai S, Jin D, Inagaki S, Tanaka K, Miyazaki M., Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9. J Mol Cell Cardiol 2007 43 670 676. doi: 10.1016/j.yjmcc.2007.08.002
15. Rizzoni D, Rodella L, Porteri E, Rezzani R, Sleiman I, Paiardi S, Guelfi D, De Ciuceis C, Boari GE, Bianchi R, Agabiti-Rosei E., Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats. Clin Exp Hypertens 2003 25 427 441
16. Petrinec D, Liao S, Holmes DR, Reilly JM, Parks WC, Thompson RW., Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996 23 336 346
17. Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, Baxter BT., Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg 2002 35 923 929
18. Shimizu K, Mitchell RN, Libby P., Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2006 26 987 994. doi: 10.1161/01.ATV.0000214999.12921.4f
19. Carson JS, Xiong W, Dale M, Yu F, Duryee MJ, Anderson DR, Thiele GM, Baxter BT., Antibodies against malondialdehyde-Acetaldehyde adducts can help identify patients with abdominal aortic aneurysm. J Vasc Surg 2015
20. Duftner C, Seiler R, Dejaco C, Chemelli-Steingruber I, Schennach H, Klotz W, Rieger M, Herold M, Falkensammer J, Fraedrich G, Schirmer M., Antiphospholipid antibodies predict progression of abdominal aortic aneurysms. PLoS One 2014 9 e99302. doi: 10.1371/journal.pone.0099302
21. Travis J., Origins. On the origin of the immune system. Science 2009 324 580 582. doi: 10.1126/science.324-580
22. Curci JA, Liao S, Huffman MD, Shapiro SD, Thompson RW., Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. J Clin Invest 1998 102 1900 1910. doi: 10.1172/JCI2182
23. Galle C, Schandené L, Stordeur P, Peignois Y, Ferreira J, Wautrecht JC, Dereume JP, Goldman M., Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm. Clin Exp Immunol 2005 142 519 527. doi: 10.1111/j.1365-2249.2005.02938.x
24. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH., Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990 137 1199 1213
25. Tsuruda T, Kato J, Hatakeyama K, Kojima K, Yano M, Yano Y, Nakamura K, Nakamura-Uchiyama F, Matsushima Y, Imamura T, Onitsuka T, Asada Y, Nawa Y, Eto T, Kitamura K., Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm. Circ Res 2008 102 1368 1377. doi: 10.1161/CIRCRESAHA.108.173682
26. Ocana E, Bohórquez JC, Pérez-Requena J, Brieva JA, Rodríguez C., Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis 2003 170 39 48
27. Forester ND, Cruickshank SM, Scott DJ, Carding SR., Increased natural killer cell activity in patients with an abdominal aortic aneurysm. Br J Surg 2006 93 46 54. doi: 10.1002/bjs.5215
28. Xiong W, Zhao Y, Prall A, Greiner TC, Baxter BT., Key roles of CD4+ T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J Immunol 2004 172 2607 2612
29. Sharma AK, Lu G, Jester A, Johnston WF, Zhao Y, Hajzus VA, Saadatzadeh MR, Su G, Bhamidipati CM, Mehta GS, Kron IL, Laubach VE, Murphy MP, Ailawadi G, Upchurch GR Jr, Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation 2012 126 11 Suppl 1 S38 S45. doi: 10.1161/CIRCULATIONAHA.111.083451
30. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjälä H, Airaksinen J, Leinonen M, Saikku P, Juvonen T., Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997 17 2843 2847
31. Karlsson L, Bergqvist D, Lindbäck J, Pärsson H., Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma. Eur J Vasc Endovasc Surg 2009 37 420 424. doi: 10.1016/j.ejvs.2008.11.027
32. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL, Haines GK, Burdick MD, Strieter RM., Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 1993 142 1423 1431
33. Szekanecz Z, Shah MR, Harlow LA, Pearce WH, Koch AE., Interleukin-8 and tumor necrosis factor-Alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth. Pathobiology 1994 62 134 139
34. Satoh H, Nakamura M, Satoh M, Nakajima T, Izumoto H, Maesawa C, Kawazoe K, Masuda T, Hiramori K., Expression and localization of tumour necrosis factor-Alpha and its converting enzyme in human abdominal aortic aneurysm. Clin Sci (Lond) 2004 106 301 306. doi: 10.1042/CS20030189
35. Galkina E, Ley K., Immune and inflammatory mechanisms of atherosclerosis (∗). Annu Rev Immunol 2009 27 165 197. doi: 10.1146/annurev.immunol.021908.132620
36. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ., Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987 316 1371 1375. doi: 10.1056/NEJM198705283162204
37. Alexander MR, Moehle CW, Johnson JL, Yang Z, Lee JK, Jackson CL, Owens GK., Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest 2012 122 70 79. doi: 10.1172/JCI43713
38. Galis ZS, Sukhova GK, Lark MW, Libby P., Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994 94 2493 2503. doi: 10.1172/JCI117619
39. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P., Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994 75 181 189
40. Ward MR, Pasterkamp G, Yeung AC, Borst C., Arterial remodeling. Mechanisms and clinical implications. Circulation 2000 102 1186 1191
41. Basta G, Schmidt AM, De Caterina R., Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 2004 63 582 592. doi: 10.1016/j.cardiores.2004.05.001
42. Vlassara H, Brownlee M, Cerami A., Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivo. Diabetes 1988 37 456 461
43. Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H., Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci U S A 1990 87 9010 9014
44. Kirstein M, Aston C, Hintz R, Vlassara H., Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J Clin Invest 1992 90 439 446. doi: 10.1172/JCI115879
45. Pleumeekers HJ, Hoes AW, van der Does E, van Urk H, Hofman A, de Jong PT, Grobbee DE., Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am J Epidemiol 1995 142 1291 1299
46. Golledge J, Karan M, Moran CS, Muller J, Clancy P, Dear AE, Norman PE., Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J 2008 29 665 672. doi: 10.1093/eurheartj/ehm557
47. Wijdeven RH, Bakker JM, Paul P, Neefjes J., Exploring genome-wide datasets of MHC class II antigen presentation. Mol Immunol 2013 55 172 174. doi: 10.1016/j.molimm.2012.10.014
48. Abbas AK, Murphy KM, Sher A., Functional diversity of helper T lymphocytes. Nature 1996 383 787 793. doi: 10.1038/383787a0
49. Zhu J, Paul WE., CD4 T cells: fates, functions, and faults. Blood 2008 112 1557 1569. doi: 10.1182/blood-2008-05-078154
50. Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA., Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol 2000 27 1128 1135
51. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, Cogswell S, Storness-Bliss C, Corry DB, Kheradmand F., Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007 13 567 569. doi: 10.1038/nm1583
52. Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg DA, Ehrenstein MR, Mauri C., Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009 182 3492 3502. doi: 10.4049/jimmunol.0803052
53. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT., Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005 6 1123 1132. doi: 10.1038/ni1254
54. Schönbeck U, Sukhova GK, Gerdes N, Libby P., T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. Am J Pathol 2002 161 499 506. doi: 10.1016/S0002-9440(10)64206-X
55. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN., Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest 2004 114 300 308. doi: 10.1172/JCI19855
56. Chan WL, Pejnovic N, Liew TV, Hamilton H., Predominance of Th2 response in human abdominal aortic aneurysm: mistaken identity for IL-4-producing NK and NKT cells? Cell Immunol 2005 233 109 114. doi: 10.1016/j.cellimm.2005.04.020
57. Wan YY, Flavell RA., How diverse-CD4 effector T cells and their functions. J Mol Cell Biol 2009 1 20 36. doi: 10.1093/jmcb/mjp001
58. Liao M, Xu J, Clair AJ, Ehrman B, Graham LM, Eagleton MJ., Local and systemic alterations in signal transducers and activators of transcription (STAT) associated with human abdominal aortic aneurysms. J Surg Res 2012 176 321 328. doi: 10.1016/j.jss.2011.05.041
59. Uchida HA, Kristo F, Rateri DL, Lu H, Charnigo R, Cassis LA, Daugherty A., Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice. Atherosclerosis 2010 211 399 403. doi: 10.1016/j.atherosclerosis.2010.02.034
60. King VL, Lin AY, Kristo F, Anderson TJ, Ahluwalia N, Hardy GJ, Owens AP 3rd, Howatt DA, Shen D, Tager AM, Luster AD, Daugherty A, Gerszten RE., Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. Circulation 2009 119 426 435. doi: 10.1161/CIRCULATIONAHA.108.785949
61. Eagleton MJ, Xu J, Liao M, Parine B, Chisolm GM, Graham LM., Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation. J Vasc Surg 2010 51 951 61; discussion 961. doi: 10.1016/j.jvs.2009.11.075
62. Wei Z, Wang Y, Zhang K, Liao Y, Ye P, Wu J, Wang Y, Li F, Yao Y, Zhou Y, Liu J., Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 2014 34 2429 2438. doi: 10.1161/ATVBAHA.114.304435
63. Yin M, Zhang J, Wang Y, Wang S, Böckler D, Duan Z, Xin S., Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2010 30 1825 1831. doi: 10.1161/ATVBAHA.109.200303
64. Xu J, Ehrman B, Graham LM, Eagleton MJ., Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice. J Surg Res 2012 178 512 518. doi: 10.1016/j.jss.2011.12.016
65. Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE, Iwakura Y, Blinder Y, Rahman A, Quyyumi AA, Harrison DG., Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 2011 31 1565 1572. doi: 10.1161/ATVBAHA.111.227629
66. Zhou Y, Wu W, Lindholt JS, Sukhova GK, Libby P, Yu X, Shi GP., Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms. Cardiovasc Res 2015
67. Postlethwaite AE, Holness MA, Katai H, Raghow R., Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 1992 90 1479 1485. doi: 10.1172/JCI116015
68. Lacraz S, Nicod L, Galve-de Rochemonteix B, Baumberger C, Dayer JM, Welgus HG., Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J Clin Invest 1992 90 382 388. doi: 10.1172/JCI115872
69. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB., Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 2010 207 1409 1420. doi: 10.1084/jem.20091885
70. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C., Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004 200 277 285. doi: 10.1084/jem.20040165
71. Smyth LJ, Starkey C, Vestbo J, Singh D., CD4-regulatory cells in COPD patients. Chest 2007 132 156 163. doi: 10.1378/chest.07-0083
72. Uhlig HH, Coombes J, Mottet C, Izcue A, Thompson C, Fanger A, Tannapfel A, Fontenot JD, Ramsdell F, Powrie F., Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 2006 177 5852 5860
73. Boschetti G, Nancey S, Sardi F, Roblin X, Flourié B, Kaiserlian D., Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis 2011 17 160 170. doi: 10.1002/ibd.21308
74. Venigalla RK, Tretter T, Krienke S, Max R, Eckstein V, Blank N, Fiehn C, Ho AD, Lorenz HM., Reduced CD4+,CD25-T cell sensitivity to the suppressive function of CD4+,CD25high,CD127-/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008 58 2120 2130. doi: 10.1002/art.23556
75. Wan S, Xia C, Morel L., IL-6 produced by dendritic cells from lupus-prone mice inhibits CD4+CD25+ T cell regulatory functions. J Immunol 2007 178 271 279
76. Keystone EC, Lau C, Gladman DD, Wilkinson S, Lee P, Shore A., Immunoregulatory T cell subpopulations in patients with scleroderma using monoclonal antibodies. Clin Exp Immunol 1982 48 443 448
77. Deleuran B, Abraham DJ., Possible implication of the effector CD4+ T-cell subpopulation TH17 in the pathogenesis of systemic scleroderma. Nat Clin Pract Rheumatol 2007 3 682 683. doi: 10.1038/ncprheum0618
78. Kisielewicz A, Schaier M, Schmitt E, Hug F, Haensch GM, Meuer S, Zeier M, Sohn C, Steinborn A., A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation. Clin Immunol 2010 137 209 220. doi: 10.1016/j.clim.2010.07.008
79. Sumpter TL, Wilkes DS., Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol 2004 286 L1129 L1139. doi: 10.1152/ajplung.00330.2003
80. Martinez FO, Sica A, Mantovani A, Locati M., Macrophage activation and polarization. Front Biosci 2008 13 453 461
81. Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro MG, Rimoldi M, Biswas SK, Allavena P, Mantovani A., Macrophage polarization in tumour progression. Semin Cancer Biol 2008 18 349 355. doi: 10.1016/j.semcancer.2008.03.004
82. Nathan C., Mechanisms and modulation of macrophage activation. Behring Inst Mitt 1991 88 200 207
83. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F., Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999 274 10689 10692
84. Samadzadeh KM, Chun KC, Nguyen AT, Baker PM, Bains S, Lee ES., Monocyte activity is linked with abdominal aortic aneurysm diameter. J Surg Res 2014 190 328 334. doi: 10.1016/j.jss.2014.03.019
85. Hance KA, Tataria M, Ziporin SJ, Lee JK, Thompson RW., Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg 2002 35 254 261
86. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD., Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006 116 753 759. doi: 10.1172/JCI25617
87. Guo G, Booms P, Halushka M, Dietz HC, Ney A, Stricker S, Hecht J, Mundlos S, Robinson PN., Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment. Circulation 2006 114 1855 1862. doi: 10.1161/CIRCULATIONAHA.105.601674
88. Guo G, Muñoz-García B, Ott CE, Grünhagen J, Mousa SA, Pletschacher A, von Kodolitsch Y, Knaus P, Robinson PN., Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice. Hum Mol Genet 2013 22 433 443. doi: 10.1093/hmg/dds439
89. Kitchens RL., Role of CD14 in cellular recognition of bacterial lipopolysaccharides. Chem Immunol 2000 74 61 82
90. Ghigliotti G, Barisione C, Garibaldi S, Brunelli C, Palmieri D, Spinella G, Pane B, Spallarossa P, Altieri P, Fabbi P, Sambuceti G, Palombo D., CD16(+) monocyte subsets are increased in large abdominal aortic aneurysms and are differentially related with circulating and cell-Associated biochemical and inflammatory biomarkers. Dis Markers 2013 34 131 142. doi: 10.3233/DMA-120956
91. Aguilar-Ruiz SR, Torres-Aguilar H, González-Domínguez É Narváez J, González-Pérez G, Vargas-Ayala G, Meraz-Ríos MA, García-Zepeda EA, Sánchez-Torres C., Human CD16+ and CD16-monocyte subsets display unique effector properties in inflammatory conditions in vivo. J Leukoc Biol 2011 90 1119 1131. doi: 10.1189/jlb.0111022
92. Blomkalns AL, Gavrila D, Thomas M, CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. J Am Heart Assoc 2013 2 e000065. doi: 10.1161/JAHA.112.000065
93. Xiong W, MacTaggart J, Knispel R, Worth J, Persidsky Y, Baxter BT., Blocking TNF-Alpha attenuates aneurysm formation in a murine model. J Immunol 2009 183 2741 2746. doi: 10.4049/jimmunol.0803164
94. Johnston WF, Salmon M, Pope NH, Meher A, Su G, Stone ML, Lu G, Owens GK, Upchurch GR Jr, Ailawadi G., Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms. Circulation 2014 130 11 Suppl 1 S51 S59. doi: 10.1161/CIRCULATIONAHA.113.006800
95. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A 3rd, Ju X, Spratt H, Guo DC, Milewicz D, Tilton RG, Brasier AR., An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 2009 119 3637 3651. doi: 10.1172/JCI38308
96. A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study of Subcutaneous ACZ885 for the Treatment of Abdominal Aortic Aneurysm. Clinical Trial: NCT02007252
97. Boytard L, Spear R, Chinetti-Gbaguidi G, Acosta-Martin AE, Vanhoutte J, Lamblin N, Staels B, Amouyel P, Haulon S, Pinet F., Role of proinflammatory CD68(+) mannose receptor(-) macrophages in peroxiredoxin-1 expression and in abdominal aortic aneurysms in humans. Arterioscler Thromb Vasc Biol 2013 33 431 438. doi: 10.1161/ATVBAHA.112.300663
98. Dutertre CA, Clement M, Morvan M, Schäkel K, Castier Y, Alsac JM, Michel JB, Nicoletti A., Deciphering the stromal and hematopoietic cell network of the adventitia from non-Aneurysmal and aneurysmal human aorta. PLoS One 2014 9 e89983. doi: 10.1371/journal.pone.0089983
99. Rateri DL, Howatt DA, Moorleghen JJ, Charnigo R, Cassis LA, Daugherty A., Prolonged infusion of angiotensin II in apoE(-/-) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am J Pathol 2011 179 1542 1548. doi: 10.1016/j.ajpath.2011.05.049
100. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S., Essential role of Stat6 in IL-4 signalling. Nature 1996 380 627 630. doi: 10.1038/380627a0
101. Brunn A, Mihelcic M, Carstov M, Hummel L, Geier F, Schmidt A, Saupe L, Utermöhlen O, Deckert M., IL-10, IL-4, and STAT6 promote an M2 milieu required for termination of P0(106-125)-induced murine experimental autoimmune neuritis. Am J Pathol 2014 184 2627 2640. doi: 10.1016/j.ajpath.2014.06.012
102. Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A., Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol 2013 228 1404 1412. doi: 10.1002/jcp.24260
103. Gazi U, Martinez-Pomares L., Influence of the mannose receptor in host immune responses. Immunobiology 2009 214 554 561. doi: 10.1016/j.imbio.2008.11.004
104. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L., Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 2000 80 617 653
105. Folkesson M, Kazi M, Zhu C, Silveira A, Hemdahl AL, Hamsten A, Hedin U, Swedenborg J, Eriksson P., Presence of NGAL/MMP-9 complexes in human abdominal aortic aneurysms. Thromb Haemost 2007 98 427 433
106. Houard X, Rouzet F, Touat Z, Philippe M, Dominguez M, Fontaine V, Sarda-Mantel L, Meulemans A, Le Guludec D, Meilhac O, Michel JB., Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms. J Pathol 2007 212 20 28. doi: 10.1002/path.2148
107. Houard X, Touat Z, Ollivier V, Louedec L, Philippe M, Sebbag U, Meilhac O, Rossignol P, Michel JB., Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res 2009 82 532 541. doi: 10.1093/cvr/cvp048
108. Eliason JL, Hannawa KK, Ailawadi G, Sinha I, Ford JW, Deogracias MP, Roelofs KJ, Woodrum DT, Ennis TL, Henke PK, Stanley JC, Thompson RW, Upchurch GR Jr, Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 2005 112 232 240. doi: 10.1161/CIRCULATIONAHA.104.517391
109. Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R, Blanco-Colio LM, Lopez JA, Camafeita E, Meilhac O, Michel JB, Aparicio C, Vega de Ceniga M, Egido J, Martín-Ventura JL., Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011 31 3011 3019. doi: 10.1161/ATVBAHA.111.237537
110. Gurish MF, Boyce JA., Mast cells: ontogeny, homing, and recruitment of a unique innate effector cell. J Allergy Clin Immunol 2006 117 1285 1291. doi: 10.1016/j.jaci.2006.04.017
111. Ihara M, Urata H, Kinoshita A, Suzumiya J, Sasaguri M, Kikuchi M, Ideishi M, Arakawa K., Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 1999 33 1399 1405
112. Mäyränpää MI, Trosien JA, Fontaine V, Folkesson M, Kazi M, Eriksson P, Swedenborg J, Hedin U., Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. J Vasc Surg 2009 50 388 95; discussion 395. doi: 10.1016/j.jvs.2009.03.055
113. Sun J, Sukhova GK, Yang M, Wolters PJ, MacFarlane LA, Libby P, Sun C, Zhang Y, Liu J, Ennis TL, Knispel R, Xiong W, Thompson RW, Baxter BT, Shi GP., Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007 117 3359 3368. doi: 10.1172/JCI31311
114. Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G., A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 2005 280 9291 9296. doi: 10.1074/jbc.M410396200
115. Furubayashi K, Takai S, Jin D, Miyazaki M, Katsumata T, Inagaki S, Kimura M, Tanaka K, Nishimoto M, Fukumoto H., Chymase activates promatrix metalloproteinase-9 in human abdominal aortic aneurysm. Clin Chim Acta 2008 388 214 216. doi: 10.1016/j.cca.2007.10.004